LIVE WEBINAR SERIES

Embracing technology to help diagnose, treat and monitor Growth Disorders


1st Webinar - 21 June 2024 from 14.00 to 15.00 CEST
2nd Webinar - 20 September 2024 from 14.00 to 15.00 CEST

CLICK TO REGISTER FOR THE WEBINARS

Overview

Clinical examination and experience are key, but can be augmented by team support, genetic techniques and artificial intelligence (AI). The ability to accurately pinpoint the growth defect allows nuanced and personalized care for the patient and their family, and optimal height outcomes.

 Technology also features in patient management, in the form of apps and therapy adherence monitoring which have proven an increase in patient engagement and compliance with medication regimes. The two webinars will be live-streamed, with opportunities for the audience to ask questions and to interact with the Chair and presenters. After each live-stream, a recording of the webinar will be posted online and will be available globally as a free, open-access resource on the MedEA e-learning platform for up to a year after launch.

Learning Objectives

After attending the live webinars participants will be able to:

Target Audience

Pediatricians, endocrinologists and general practitioners involved in growth management.

Language

The official language of this live educational programme will be English. Simultaneous translation into Spanish and Korean will be provided.

Continuing Medical Education
(CME)

The Embracing technology to help diagnose, treat and monitor Growth Disorders will be submitted for CME accreditation from the European Accreditation Council for Continuing Medical Education (EACCME), and/ or the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) and for Continuing Professional Development (CPD) credits.

Embracing technology to help diagnose, treat and monitor Growth Disorders

Live Webinar Series
21 June 2024 · from 14.00 to 15.00 CEST

20 September 2024 · from 14.00 to 15.00 CEST

Faculty

Justin Davies

Justin Davies

Professor of Paediatric Endocrinology
University of Southampton
Southampton, UK
Paul Dimitri

Paul Dimitri

Professor of Child Health Technology at the University of Sheffield and
Professor of Child Health at Sheffield Hallam University
Consultant in Paediatric Endocrinology and Director of Technology & Innovation at the Sheffield Children’s NHS Foundation Trust UK
Sheffield, UK
Luis Fernandez-Luque

Luis Fernandez-Luque

Adhera Health Inc,
Santa Cruz, CA, USA
Martin O. Savage

Martin O. Savage

Emeritus Professor of Paediatric Endocrinology
William Harvey Research Institute
Barts and the London School of Medicine and Dentistry
Queen Mary, University of London, UK
Laura-Maria Peltonen

Laura-Maria Peltonen

Adjunct Professor
Department of Nursing Science
University of Turku and Research Services
Wellbeing Services County of Southwest Finland
Turku, Finland
Richard JM Ross

Richard JM Ross

Professor of Endocrinology
University of Sheffield
Sheffield, UK

International Committee

Jeff Bolton

Jeff Bolton

Chair of Trustees
Child Growth Foundation
UK
Tabitha Randell

Tabitha Randell

Chair of the British Society for Paediatric Endocrinology and Diabetes (BSPED)
Consultant in Paediatric Endocrinology and Diabetes
Nottingham Children’s Hospital Nottingham, UK

Partnerships

Agenda

AGENDA

Final Programme

1st Webinar 21 June

· Justin Davies ·

Justin Davies is a Consultant Paediatric Endocrinologistand Honorary Associate Professorat Southampton Children’s Hospital and the University of Southampton. He is theService Lead for paediatric endocrinology at Southamptonand also leads the Paediatric Metabolic Bone service with a multidisciplinary team dedicated to rare bone disease and childhood osteoporosis. His research interestsinclude secondary osteoporosis, impact of disease on body composition and imprinting disorders.Dr Davies was Chairman of the British Society of Paediatric Endocrinology and Diabetes 2016-2020. He is the service lead for the European Reference Centre -Southampton for Rare Bone Disease and Endocrinology (Growth disorders). His other national roles have included the Secretary of the British Paediatric and Adolescent Bone Group,Treasurer of the British Society of Paediatric Endocrinology and Diabetes.Dr Davies leads an international school for paediatric endocrinology -the European Society for Paediatric Endocrinology, Winter School.

· Paul Dimitri ·

Paul Dimitri is the Director of the National Institute for Health Research (NIHR) HealthTech Research Centre in Paediatrics and Child Health, and the Clinical Director for the National Technology Innovation Transforming Child Health (TITCH) Network (www.titch.org.uk). He has previously held national positions on UK national committees at the Royal College of Paediatrics and Child Health (RCPCH), and the Academy of the Medical Royal Colleges, and is the current Vice President for Science and Research at the RCPCH. He was NIHR National Children’s Specialty Lead, UK from 2016-2024. Paul is leading on the development of the National Centre for Child Health Technology, a global first bringing together industry, universities, healthcare professionals, children and young people and their families to develop the most advanced healthcare technologies for children worldwide. Paul has led on the development and implementation of national technology networks that specifically focus on the development and deployment of technology for paediatrics and child health through private and public sector collaboration. Paul currently works at Sheffield Children’s NHS Foundation Trust UK as a Consultant in Paediatric Endocrinology and Director of Technology & Innovation. He is Professor of Child Health Technology at the University of Sheffield and Professor of Child Health at Sheffield Hallam University.

· Martin O. Savage ·

Martin Savage is Emeritus Professor of Paediatric Endocrinology at William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary, University of London. He was head of the Paediatric Endocrine Unit at Barts and the London School of Medicine from 1982 to 2007. He has interests in growth disorders, specifically those with abnormalities in the GH-IGF-1 axis and in phenotype-genotype relationships of GH-IGF-1 axis defects, notably GH resistance. He published the first human case of an IGF-1 gene defect in the New England Journal of Medicine in 1996.  His other interests are Cushing’s syndrome and growth in chronic inflammatory diseases. He was General Secretary of the European Society for Paediatric Endocrinology (ESPE) from 1997 to 2004. He has lectured in 60 countries and has published 482 original articles, reviews, textbook chapters and books. In 2007, he was awarded the ESPE Andrea Prader Prize for contributions to paediatric endocrinology and in 2018 he received a Visionary Award from the American Human Growth Foundation. In 2022, he received a Research Excellence Award from the Dr Sulaiman Al Habib Medical Journal in Riyadh, and the British Society of Paediatric Endocrinology & Diabetes James M. Tanner Lifetime Achievement Award. He continues to lecture nationally and internationally.

· Richard JM Ross ·

Richard JM Ross trained in medicine at The Royal London Hospital (1974-1979) and in Endocrinology at St Bartholomew’s Hospital, London (1983-1988). Appointed to Sheffield University in 1995 and is Professor of Endocrinology, past Head of Section and currently theme lead for Diabetes, Endocrinology and Metabolism. Retired from clinical practice in 2021. Richard’s research and clinical interests are in pituitary and adrenal disease, transition endocrinology and the late effects of cancer. Richard was Chief Scientific Officer and Director on the Board of Diurnal Group Plc (2004-2022); overseeing its flotation in 2015 on the London Stock market (AIM) prior to its purchase by Neurocrine Biosciences in 2022. Served on the editorial boards of: Clinical Endocrinology (1996-2000), Growth & Growth Factors (1986-2006), Hormones (2004-2018), and J Clin Endocrinol Metab (2010-2014). Council member for the Society of Endocrinology (1999-2002), Editor Endocrinologist (2001-2004), Chair of CaHASE (2002-2015), member of the Bioscientifica Board (2006-2010), Society for Endocrinology Public Engagement Committee (2008-2011) and Nominations Committee (2010-2012). Executive Committee of the European Society of Endocrinology (2011-2015), Treasurer of the European Society of Endocrinology (2013-2015), The Growth Hormone Research Society Council (2011-2018), and The Pituitary Society Board of Directors (2019-). Received The Endocrine Societies “Outstanding Innovation Award” in 2021 and awarded the Clinical

· Jeff Bolton ·

A BSc (Hons) and MBA graduate from Welsh universities, Jeff joined the pharmaceutical industry in 1990. Jeff first worked for Janssen-Cilag, where he performed a number of commercial and marketing management roles.

Jeff joined Pfizer in 2002 as Senior Brand Manager in the Endocrinology Team and transitioned into a European marketing role in 2006. Jeff became European Brand Director in 2010. Jeff left Pfizer in 2016 to start his own consultancy company, JRB Consultancy Services Ltd.

Jeff has been involved with growth conditions for over 20 years, and has won numerous awards, both national and international, for his role in developing campaigns and support information and materials for families affected by growth conditions. Jeff was the European lead for the development of the first growth prediction tool, iGRO, which was sponsored by Pfizer, and has since been rolled out in more than 25 countries.

Jeff has been a trustee of the Child Growth Foundation for over two years and became their Chair in 2022.

· Tabitha Randell ·

Dr Tabitha Randell is a Consultant in Paediatric Endocrinology and Diabetes based at Nottingham Children’s Hospital, UK. She has over 25 years’ experience of working in paediatric diabetes and endocrinology, 20 years as a consultant, undergoing her training in both the UK and Australia. She is the current chair of the British Society for Paediatric Endocrinology and Diabetes (BSPED), elected in 2019 and taking up the role in 2020 following a year’s shadowing. She previously chaired the BSPED Clinical Committee from 2016-2020 and was the BSPED’s inaugural Media Officer from 2008-2012.